Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 369,821 |
|
|||||
| News | - | ||||||
| Day High | 38.47 | Low High |
|||||
| Day Low | 37.03 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Collegium Pharmaceutical Inc | COLL | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.85 | 2.30% | 37.78 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 37.12 | 37.03 | 38.47 | 37.78 | 36.93 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,544 | 369,821 | US$ 37.89 | US$ 14,011,854 | - | 20.83 - 40.95 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:32:53 | priorref | 26,400 | US$ 37.78 | USD |
Collegium Pharmaceutical Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.21B | 31.96M | - | 566.77M | 48.16M | 1.51 | 25.07 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Collegium Pharmaceutical News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical COLL Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 35.83 | 38.47 | 35.05 | 36.27 | 296,734 | 1.95 | 5.44% |
| 1 Month | 38.25 | 40.49 | 34.24 | 36.63 | 335,215 | -0.47 | -1.23% |
| 3 Months | 33.34 | 40.95 | 31.34 | 36.84 | 435,781 | 4.44 | 13.32% |
| 6 Months | 21.80 | 40.95 | 21.40 | 32.88 | 421,023 | 15.98 | 73.30% |
| 1 Year | 22.98 | 40.95 | 20.83 | 28.52 | 362,358 | 14.80 | 64.40% |
| 3 Years | 22.43 | 40.95 | 14.04 | 23.73 | 334,506 | 15.35 | 68.44% |
| 5 Years | 13.95 | 40.95 | 10.01 | 21.68 | 369,977 | 23.83 | 170.82% |
Collegium Pharmaceutical Description
| Collegium Pharmaceutical Inc is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol. |
